Literature DB >> 1485529

Plasma homocysteine in vascular disease and in nonvascular dementia of depressed elderly people.

I R Bell1, J S Edman, J Selhub, F D Morrow, D W Marby, H L Kayne, J O Cole.   

Abstract

Depression among elderly people with reversible cognitive loss often manifests with concomitant vascular disease and can also precede the development of nonvascular degenerative dementia. Little is known about etiological factors for reversible or irreversible dementias in older depressed people. The amino acid homocysteine (HC), which is both a vascular disease risk factor and a precursor of the excitotoxic amino acids cysteine and homocysteic acid, could play a role in the pathophysiology of such individuals. Twenty-seven depressed elderly acute inpatients by DSM-III-R criteria had significantly higher plasma homocysteine levels and lower cognitive screening test scores than did 15 depressed young adult inpatients. HC was highest in the older patients who had concomitant vascular diseases (n = 14). HC was lowest in the older depressives who had neither vascular illnesses nor dementia (n = 8), comparable to the young adult depressives. Higher HC correlated significantly with poorer cognition only in the nonvascular geriatric patients (rs = -0.53). The findings extend earlier work showing higher HC in vascular patients from general medical populations, and also suggest a possible metabolic factor in certain dementias associated with late-life depression.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1485529     DOI: 10.1111/j.1600-0447.1992.tb03285.x

Source DB:  PubMed          Journal:  Acta Psychiatr Scand        ISSN: 0001-690X            Impact factor:   6.392


  16 in total

1.  Short-term cognition deficits during early alcohol withdrawal are associated with elevated plasma homocysteine levels in patients with alcoholism.

Authors:  J Wilhelm; K Bayerlein; T Hillemacher; U Reulbach; H Frieling; B Kromolan; D Degner; J Kornhuber; S Bleich
Journal:  J Neural Transm (Vienna)       Date:  2005-07-06       Impact factor: 3.575

Review 2.  Age-related changes in cobalamin (vitamin B12) handling. Implications for therapy.

Authors:  H Nilsson-Ehle
Journal:  Drugs Aging       Date:  1998-04       Impact factor: 3.923

3.  Synergistic Toxicity of the Neurometabolites Quinolinic Acid and Homocysteine in Cortical Neurons and Astrocytes: Implications in Alzheimer's Disease.

Authors:  Paula Pierozan; Helena Biasibetti-Brendler; Felipe Schmitz; Fernanda Ferreira; Carlos Alexandre Netto; Angela T S Wyse
Journal:  Neurotox Res       Date:  2017-11-09       Impact factor: 3.911

4.  Homocysteine and related genetic polymorphisms in Down's syndrome IQ.

Authors:  J-L Guéant; G Anello; P Bosco; R-M Guéant-Rodríguez; A Romano; C Barone; P Gérard; C Romano
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-05       Impact factor: 10.154

5.  Homozygous thermolabile methylenetetrahydrofolate reductase in schizophrenia-like psychosis.

Authors:  B Regland; T Germgård; C G Gottfries; B Grenfeldt; A C Koch-Schmidt
Journal:  J Neural Transm (Vienna)       Date:  1997       Impact factor: 3.575

6.  Homocysteine accumulates in supernatants of stimulated human peripheral blood mononuclear cells.

Authors:  K Schroecksnadel; B Frick; B Wirleitner; H Schennach; D Fuchs
Journal:  Clin Exp Immunol       Date:  2003-10       Impact factor: 4.330

7.  The S-adenosyl homocysteine hydrolase inhibitor 3-deaza-adenosine prevents oxidative damage and cognitive impairment following folate and vitamin E deprivation in a murine model of age-related, oxidative stress-induced neurodegeneration.

Authors:  Thomas B Shea; David Ashline; Daniela Ortiz; Shelia Milhalik; Eugene Rogers
Journal:  Neuromolecular Med       Date:  2004       Impact factor: 3.843

Review 8.  The role of B vitamins in preventing and treating cognitive impairment and decline.

Authors:  Martha Savaria Morris
Journal:  Adv Nutr       Date:  2012-11-01       Impact factor: 8.701

9.  Total homocysteine and cognition in a tri-ethnic cohort: the Northern Manhattan Study.

Authors:  C B Wright; H-S Lee; M C Paik; S P Stabler; R H Allen; R L Sacco
Journal:  Neurology       Date:  2004-07-27       Impact factor: 9.910

10.  Laxative treatment elevates plasma homocysteine: a study on a population-based Swedish sample of old people.

Authors:  Sven E Nilsson; Sanna Takkinen; Boo Johansson; Gerhard Dotevall; Arne Melander; Stig Berg; Gerald McClearn
Journal:  Eur J Clin Pharmacol       Date:  2004-02-07       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.